TITLE

Expression and Characterization of Bioactive Human Thrombopoietin in the Milk of Transgenic Mice

AUTHOR(S)
Sohn, Bo Hwa; Kim, Sun Jung; Park, Heungrok; Park, Seung Kook; Lee, Sang Chul; Hong, Hyo Jeong; Park, Young Sik; Lee, Kyung-Kwang
PUB. DATE
November 1999
SOURCE
DNA & Cell Biology;Nov99, Vol. 18 Issue 11, p845
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Human thrombopoietin (hTPO) is the primary physiological regulator of platelet production and plays a pivotal role in promoting the proliferation and maturation of megakaryocytic progenitor cells and megakaryocytes. In this study, transgenic mice were produced harboring either full-length or the erythropoietin (EPO)-like amino-terminal domain of hTPO cDNA sequences fused to the regulatory elements of the bovine beta-casein gene. The transgene RNA was expressed exclusively in the mammary glands of eight transgenic mice, and a trace amount of the transgene was also found in the lungs of one mouse. The full-length form induced efficient expression of the protein with the highest expression level of 1500 mu g/ml; however, the EPO-like domain alone expressed the protein at <0.1 mu g/ml. The proteins from the two recombinant cDNAs have apparent molecular weights of about 74 and 17 kDa, due to glycosylation in the case of the full-length cDNA. Cell proliferation assay in vitro indicated that both of the recombinant forms stimulated proliferation of the TPO-dependent BaF3-Mpl cells. A positive correlation appeared between the amount of TPO in the milk of lactating animals and their blood platelet levels. About a twofold increase in platelet numbers in the blood was observed after direct subcutaneous injection of the recombinant hTPO at the level of 30 mu g/kg of body weight. On the basis of these results, we anticipate that the recombinant hTPO produced efficiently in milk of transgenic mice will have the same activities as the native hTPO in a few in vivo as well as in vitro biochemical aspects.
ACCESSION #
6778151

 

Related Articles

  • Mice Rendered Severely Deficient in Megakaryocytes through Targeted Gene Deletion of the Thrombopoietin Receptor c-Mpl Have a Normal Skeletal Phenotype. Perry, Mark J.; Redding, Katrina A.; Alexander, Warren S.; Tobias, Jonathan H. // Calcified Tissue International;Sep2007, Vol. 81 Issue 3, p224 

    To explore whether a functional relationship exists between megakaryocytes and the cellular processes responsible for bone formation, we examined if Mpl −/− mice, which are severely megakaryocyte-deficient through c-Mpl gene deletion, have an abnormal skeletal phenotype compared to...

  • High Concentrations of Thrombopoietin Activate Platelets In Vitro. Hammond, William P.; Wun, Theorode; Kaplan, Alexander; Kaplan, Svetlana; Paglieroni, Teresa; Kaushansky, Kenneth; Foster, Donald C. // Clinical & Applied Thrombosis/Hemostasis;Jul1998, Vol. 4 Issue 3, p170 

    Thrombopoietin (TPO), the ligand for the protooncogene c-mpl has been cloned and expressed from both human and murine sources. Thrombopoietin increases platelet counts when given in vivo and acts on progenitor cells to increase their proliferation and maturation into megakaryocytes. The effects...

  • A novel MPL point mutation resulting in thrombopoietin-independent activation. Abe, M.; Suzuki, K. // Leukemia (08876924);Aug2002, Vol. 16 Issue 8, p1500 

    Thrombopoietin (TPO) and its receptor (MPL) are important regulators of megakaryopoiesis. MPL belongs to a cytokine receptor superfamily. To date, all constitutively active MPL mutants have been artificially constructed with amino acid substitutions in the transmembrane domain or extracellular...

  • CORRECTIONS.  // Journal of Biochemistry;1996, Vol. 119 Issue 1, p208 

    In the paper entitled “Purification and Characterization of Thrombopoietin” by Takasbi Kato, Kinya Ogami, Yoshihiro Shimada, Akibiro Iwamatsu, Yoshiaki Sohma, Hiromichi Akahori, Kaori Hone, Atsuko Kokubo, Yoko Kudo, Emiko Maeda, Keiko Kobayashi, Hideya Ohashi, Tadasbi Ozawa, Hideo...

  • Marrow mesenchymal stem cells transduced with TPO/FL genes as support for ex vivo expansion of hematopoietic stem/progenitor cells. Xie, C.-G.; Wang, J.-F.; Xiang, Y.; Jia, B.-B.; Qiu, L.-Y.; Wang, L.-J.; Wang, G.-Z.; Huang, G.-P. // Cellular & Molecular Life Sciences;Nov2005, Vol. 62 Issue 21, p2495 

    A new marrow-derived mesenchymal stem cell (hMSC) line that could support expansion of hematopoietic stem/progenitor cells (HSPCs) was developed. Primary hMSCs were infected with retrovirus containing Flt-3 ligand and thrombopoietin genes. CD34+ cells from cord blood were expanded with primary...

  • High Doses of Romiplostim Induce Proliferation and Reduce Proplatelet Formation by Human Megakaryocytes. Currao, Manuela; Balduini, Carlo L.; Balduini, Alessandra; Lin, Baochuan // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    Background: Romiplostim (AMG531) is a Thrombopoietin (TPO) receptor agonist with no homology with the endogenous TPO that has been used to treat patients affected by immune thrombocytopenia (ITP). Despite the use of TPO mimetics in the clinical practice, the mechanisms underlying their impact on...

  • Megakaryocytic differentiation of human progenitor cells is negatively influenced by direct contact with stroma. Zweegman, S; Veenhof, M A; Debili, N; Schuurhuis, G J; Huijgens, P C; Dräger, A M // Leukemia (08876924);Jun99, Vol. 13 Issue 6, p935 

    The recently defined ligand for the Mpl receptor, thrombopoie-tin (TPO), has been found to be the principal regulatory cyto-kine of megakaryocytopoiesis. Furthermore, it has been hypothesized that direct interaction between stroma or stroma-derived extracellular matrix (ECM) and human progenitor...

  • Thrombopoietin as a Drug: Biologic Expectations, Clinical Realities, and Future Directions. Haznedaroglu, Ibrahim C.; Goker, Hakan; Turgut, Mehmet; Buyukasik, Yahya; Benekli, Mustafa // Clinical & Applied Thrombosis/Hemostasis;Jul2002, Vol. 8 Issue 3, p193 

    After the cloning of thrombopoietin (c-mpl ligand, Tpo) in 1994, 2 recombinam thrombopoietic growth factors, full-length glycosylated recombinant human Tpo (reHuTPO) and polyethylene glycol conjugated megakaryocyte growth and development factor (PEG-reHuMGDF), have been studied in humans in a...

  • Two candidate genes for low platelet count identified in an Asian Indian kindred by genome-wide linkage analysis: glycoprotein IX and thrombopoietin. Garner, Chad; Best, Steve; Menzel, Stephan; Rooks, Helen; Spector, Tim D.; Thein, Swee Lay // European Journal of Human Genetics;Jan2006, Vol. 14 Issue 1, p101 

    A genome-wide linkage analysis of platelet count was carried out in a large Asian Indian kindred. Linkage analysis showed one marker (D3S1309) on chromosome 3q with a lod score of 3.26 and another (D3S1282) approximately 30 cM centromeric, with a lod score of 2.52. Multipoint analysis of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics